Low dose of donepezil improves gabapentin analgesia in the rat spared nerve injury model of neuropathic pain: Single and multiple dosing studies

Journal of Neural Transmission

Volumn 117, Issue 12, 2010, Pages 1377-1385

  Folkesson, Anna ^a   Honoré, Per Hartvig ^a   Andersen, Lene Munkholm ^a   Kristensen, Pernille ^a   Bjerrum, Ole J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Combination pharmacotherapy; Donepezil; Gabapentin; Neuropathic pain; Spared nerve injury model

Indexed keywords

DONEPEZIL; GABAPENTIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; DRUG TOLERANCE; LOW DRUG DOSE; MALE; MONOTHERAPY; MORNING DOSAGE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TREATMENT OUTCOME;

AMINES; ANALGESICS; ANIMALS; CHOLINESTERASE INHIBITORS; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG SYNERGISM; GAMMA-AMINOBUTYRIC ACID; INDANS; MALE; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78651239450     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0494-4     Document Type: Article

References (35)

1. N Attal G Cruccu M Haanpaa P Hansson TS Jensen T Nurmikko C Sampaio S Sindrup P Wiffen 2006 EFNS guidelines on pharmacological treatment of neuropathic pain Eur J Neurol 13 1153 1169 1:STN:280:DC%2BD28ngs1Smug%3D%3D 10.1111/j.1468-1331.2006.01511.x 17038030 (Pubitemid 44581463)
2. K Bachmann D Pardoe D White 1996 Scaling basic toxicokinetic parameters from rat to man Environ Health Perspect 104 400 407 1:CAS:528:DyaK28XjsVeksrw%3D 10.2307/3432684 8732950
3. E Bruera F Strasser L Shen JL Palmer J Willey LC Driver AW Burton 2003 The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study J Pain Symptom Manage 26 1049 1054 1:CAS:528:DC%2BD3sXpvVOmt70%3D 10.1016/S0885-3924(03)00332-4 14585555 (Pubitemid 37324685)
4. JE Caldwell 2009 Clinical limitations of acetylcholinesterase antagonists J Crit Care 24 21 28 1:CAS:528:DC%2BD1MXnslKrtbY%3D 10.1016/j.jcrc.2008.08.003 19272535
5. BA Clayton K Hayashida SR Childers R Xiao JC Eisenach 2007 Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism Anesthesiology 106 1019 1025 1:CAS:528:DC%2BD2sXksFemtrc%3D 10.1097/01.anes.0000265163.22007.6d 17457135 (Pubitemid 46684070)
6. I Decosterd CJ Woolf 2000 Spared nerve injury: an animal model of persistent peripheral neuropathic pain Pain 87 149 158 1:STN:280: DC%2BD3cvosVSntw%3D%3D 10.1016/S0304-3959(00)00276-1 10924808 (Pubitemid 30621447)
7. S Dronfield K Egan CA Marsden AR Green 2000 Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat J Psychopharmacol 14 275 279 1:CAS:528:DC%2BD3cXovVeqsro%3D 10.1177/026988110001400301 11106308
8. RH Dworkin AB O'Connor M Backonja JT Farrar NB Finnerup TS Jensen EA Kalso JD Loeser C Miaskowski TJ Nurmikko RK Portenoy AS Rice BR Stacey RD Treede DC Turk MS Wallace 2007 Pharmacologic management of neuropathic pain: evidence-based recommendations Pain 132 237 251 1:CAS:528:DC%2BD2sXht1yls7nN 10.1016/j.pain.2007.08.033 17920770 (Pubitemid 350051570)
9. JC Eisenach 1999 Muscarinic-mediated analgesia Life Sci 64 549 554 1:CAS:528:DyaK1MXoslCgsQ%3D%3D 10.1016/S0024-3205(98)00600-6 10069522 (Pubitemid 29066705)
10. A Folkesson P Hartvig Honoré OJ Bjerrum 2010 Co-administered gabapentin and venlafaxine in nerve injured rats: effect on mechanical hypersensitivity, motor function and pharmacokinetics Scand J Pain 1 91 97 10.1016/j.sjpain.2009.12.001
11. I Gilron 2007 Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions Curr Opin Anaesthesiol 20 456 472 10.1097/ACO.0b013e3282effaa7 17873599 (Pubitemid 47415136)
12. I Gilron MB Max 2005 Combination pharmacotherapy for neuropathic pain: current evidence and future directions Expert Rev Neurother 5 823 830 1:CAS:528:DC%2BD2MXhtlWmtrzO 10.1586/14737175.5.6.823 16274339 (Pubitemid 41679649)
13. N Harden M Cohen 2003 Unmet needs in the management of neuropathic pain J Pain Symptom Manage 25 S12 S17 10.1016/S0885-3924(03)00065-4 12694988 (Pubitemid 36411837)
14. Hartvig P, Gillberg PG, Gordh T Jr, Post C (1989) Cholinergic mechanisms in pain and analgesia. Trends Pharmacol Sci (Suppl), pp 75-79
15. KI Hayashida T Bynum M Vincler JC Eisenach 2006 Inhibitory M2 muscarinic receptors are upregulated in both axotomized and intact small diameter dorsal root ganglion cells after peripheral nerve injury Neuroscience 140 259 268 1:CAS:528:DC%2BD28XksVGis7o%3D 10.1016/j.neuroscience.2006.02.013 16580144 (Pubitemid 43668444)
16. K Hayashida S DeGoes R Curry JC Eisenach 2007 Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery Anesthesiology 106 557 562 1:CAS:528:DC%2BD2sXitFylt7k%3D 10.1097/00000542-200703000-00021 17325515 (Pubitemid 46662222)
17. K Hayashida R Parker JC Eisenach 2007 Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil Anesthesiology 106 1213 1219 1:CAS:528:DC%2BD2sXls1yit74%3D 10.1097/01.anes.0000267605.40258.98 17525597 (Pubitemid 46828175)
18. K Hayashida H Obata K Nakajima JC Eisenach 2008 Gabapentin acts within the locus coeruleus to alleviate neuropathic pain Anesthesiology 109 1077 1084 1:CAS:528:DC%2BD1cXhsVajt7rK 10.1097/ALN.0b013e31818dac9c 19034104
19. JH Hwang KS Hwang JK Leem PH Park SM Han DM Lee 1999 The antiallodynic effects of intrathecal cholinesterase inhibitors in a rat model of neuropathic pain Anesthesiology 90 492 499 1:CAS:528:DyaK1MXhtlSis7g%3D 10.1097/00000542- 199902000-00025 9952157 (Pubitemid 29071519)
20. S Jackson RJ Ham D Wilkinson 2004 The safety and tolerability of donepezil in patients with Alzheimer's disease Br J Clin Pharmacol 58 Suppl 1 1 8 1:CAS:528:DC%2BD2cXhtFahur7E 10.1111/j.1365-2125.2004.01848.x 15496217
21. MW Jann KL Shirley GW Small 2002 Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors Clin Pharmacokinet 41 719 739 1:CAS:528:DC%2BD38XntFyrurk%3D 10.2165/00003088-200241100-00003 12162759
22. P Lavand'homme HL Pan JC Eisenach 1998 Intrathecal neostigmine, but not sympathectomy, relieves mechanical allodynia in a rat model of neuropathic pain Anesthesiology 89 493 499 10.1097/00000542-199808000-00027 9710409 (Pubitemid 28373440)
23. DR Liston JA Nielsen A Villalobos D Chapin SB Jones ST Hubbard IA Shalaby A Ramirez D Nason WF White 2004 Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease Eur J Pharmacol 486 9 17 1:CAS:528:DC%2BD2cXnvVOrtg%3D%3D 10.1016/j.ejphar.2003.11.080 14751402 (Pubitemid 38130155)
24. K Matsui M Mishima Y Nagai T Yuzuriha T Yoshimura 1999 Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat Drug Metab Dispos 27 1406 1414 1:CAS:528: DyaK1MXnslylur0%3D 10570021
25. VC Moser 1989 Screening approaches to neurotoxicity: a functional observational battery J Am Coll Toxicol 8 85 93 1:CAS:528:DyaL1MXhs1Omu7o%3D
26. VC Moser 1990 Approaches for assessing the validity of a functional observational battery Neurotoxicol Teratol 12 483 488 1:CAS:528: DyaK3cXlvVKiurs%3D 10.1016/0892-0362(90)90011-Z 2247036
27. VC Moser JP McCormick JP Creason RC MacPhail 1988 Comparison of chlordimeform and carbaryl using a functional observational battery Fundam Appl Toxicol 11 189 206 1:CAS:528:DyaL1cXlt1CisLw%3D 10.1016/0272-0590(88)90144-3 3146518
28. CL Pellandra 1933 La geneserine-morphine adjuvant de l'anésthesie générale Lyon Medical 151 653 655
29. R Poyhia M Xu VK Kontinen S Paananen E Kalso 1999 Systemic physostigmine shows antiallodynic effects in neuropathic rats Anesth Analg 89 428 433 1:STN:280:DyaK1MzmvVKgsQ%3D%3D 10.1097/00000539-199908000-00033 10439760 (Pubitemid 29367729)
30. K Takasu M Honda H Ono M Tanabe 2006 Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury Br J Pharmacol 148 233 244 1:CAS:528: DC%2BD28XksFSgu7w%3D 10.1038/sj.bjp.0706731 16582934 (Pubitemid 43873042)
31. Y Takeuchi K Takasu M Honda H Ono M Tanabe 2007 Neurochemical evidence that supraspinally administered gabapentin activates the descending noradrenergic system after peripheral nerve injury Eur J Pharmacol 556 69 74 1:CAS:528:DC%2BD2sXls1GhtQ%3D%3D 10.1016/j.ejphar.2006.10.059 17141754 (Pubitemid 46074002)
32. M Tanabe K Takasu N Kasuya S Shimizu M Honda H Ono 2005 Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse Br J Pharmacol 144 703 714 1:CAS:528:DC%2BD2MXisVSiu7k%3D 10.1038/sj.bjp.0706109 15678083 (Pubitemid 40445619)
33. M Tanabe K Takasu Y Takeuchi H Ono 2008 Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury J Neurosci Res 86 3258 3264 1:CAS:528:DC%2BD1cXhsVarurfE 10.1002/jnr.21786 18655202
34. Vollmer KO, von HA, Kolle EU (1986) Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittelforschung 36:830-839
35. M Zimmermann 1983 Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 109 110 1:STN:280:DyaL3s3nt1GqsQ%3D%3D 10.1016/0304-3959(83)90201-4 6877845 (Pubitemid 13058546)